Bawang, Mona O.
HRN: 01-79-17 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/06/2024
CEFTRIAXONE 1G (VIAL)
04/06/2024
04/12/2024
IVTT
2g
OD
Cap-MR; Uti
Waiting Final Action
Indication: Empiric Type of Infection: Urinary TractPneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes